View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
March 24, 2021

Medical Devices industry cross border venture financing deals total $352.63m globally in February 2021

The $90m venture financing of Hyperfine Research was the medical devices industry’s top cross border venture financing deal as total deals worth $352.63m were announced globally in February 2021, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

The value marked a decrease of 9.7% over the previous month of $390.33m and a drop of 17.5% when compared with the last 12-month average, which stood at $427.37m.

Comparing cross border venture financing deals value in different regions of the globe, North America held the top position, with total announced deals in the period worth $250.8m. At the country level, the US topped the list in terms of deal value at $236.8m.

In terms of volumes, Europe emerged as the top region for medical devices industry cross border venture financing deals globally, followed by North America and then Middle East and Africa.

The top country in terms of cross border venture financing deals activity in February 2021 was the US with seven deals, followed by the UK with three and France with three.

In 2021, as of February, medical devices cross border venture financing deals worth $742.96m were announced globally, marking a decrease of 3.4% year on year.

medical devices industry cross border venture financing deals in February 2021: Top deals

The top five medical devices industry cross border venture financing deals accounted for 70.8% of the overall value during February 2021.

The combined value of the top five medical devices cross border venture financing deals stood at $249.77m, against the overall value of $352.63m recorded for the month.

The top five medical devices industry cross border venture financing deals of February 2021 tracked by GlobalData were:

1) Altium Capital, Axiom Associates, Colle Capital Partners, GV Management Co, Huamin Investment Management and Nextrans’ $90m venture financing of Hyperfine Research

2) The $68m venture financing of Syapse by Ally Bridge Group and Northpond Ventures

3) Orbimed Advisors and WuXi Huiying Investment’ $40m venture financing of Guangzhou Benchmark Medical

4) The $30m venture financing of MediSafe Project by 7wireVentures, ALIVE Israel HealthTech Fund, Consensus Business Group, Leumi Partners, Lool Ventures, M Ventures, Menora Mivtachim Holdings, Octopus Ventures, OurCrowd, Pitango HealthTech, Qualcomm Ventures, Sanofi Ventures and TriVentures

5) Andera Partners, Asabys Partners, Caixa Capital Risc SGEIC, Center for the Development of Industrial Technology, Innogest Capital II and VI Partners’ venture financing of Medlumics for $21.77m.

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Medical Device Network